Small deals make up the IPO Calendar for this short holiday week, which began with Presidents Day. The U.S. stock market was closed Monday, Feb. 19, 2024, for the federal holiday. Most IPO investors are keeping an eye out for news about potential big deals on the horizon such as Reddit, which has not filed its […]
February 20, 2024 Read MoreUnusual Machines, Inc. (UMAC), a drone technology company based in San Juan, Puerto Rico, upsized its micro-cap IPO at pricing to 1.25 million shares – up from 1.0 million shares in the prospectus – and priced the deal at $4.00 – the low end of its $4.00-to-$6.00 range – to raise $5.0 million on Tuesday […]
February 14, 2024 Read MoreBBB Foods, Inc. (TBBB), the parent of Mexico’s Tiendas 3B discount grocery store chain, priced its upsized IPO at $17.50 – the top of its recently increased range – on 33.66 million shares – the number of shares in its revised prospectus – to raise $589.05 million on Thursday night (Feb. 8, 2024). Shares of […]
February 9, 2024 Read MoreBBB Foods, Inc. (TBBB proposed), the parent of Mexico’s discount grocery store chain, increased its IPO’s size early today to $572.2 million by raising both the number of shares and the price range – hours ahead of the IPO’s pricing, expected tonight after the market’s close. The IPO’s size was raised to 33.66 million shares […]
February 8, 2024 Read MoreClinical biotech Kyverna Therapeutics (KYTX) priced its upsized IPO at $22.00 – $1.00 above its recently increased range – on 14.5 million shares – the number of shares in the prospectus – to raise $319 million on Wednesday night (Feb. 7, 2024). The $22.00 IPO price exceeded Kyverna’s price range of $20.00 to $21.00, which was disclosed on Tuesday […]
Read MoreKyverna Therapeutics (KYTX Proposed) increased its IPO’s size by 48.5 percent early today – Tuesday, Feb. 6, 2024 – by raising both the number of shares and the price range, according to an S-1/A filing. The new terms: 14.5 million shares – up from 11.12 million originally – at $20.00 to $21.00 – up from […]
February 6, 2024 Read MoreIt’s all in the genes. Metagenomi, Inc. (MGX Proposed), a preclinical gene editing company backed by COVID-19 vaccine maker Moderna, disclosed terms for its IPO early today (Monday, Feb. 5, 2024) and launched the deal to price on Thursday night, Feb. 8, 2024. The stock is expected to trade Friday, Feb. 9, on the NASDAQ. J.P. […]
February 5, 2024 Read MoreMexico’s hard discount grocery store chain BBB Foods Inc. (TBBB Proposed) set terms for its IPO today and launched the deal for pricing next week. BBB Foods’ no-frills grocery stores are in the same category as Germany’s Aldi and Lidl chains. The Mexico City-based discount grocery chain plans to offer 28.05 million Class A ordinary […]
February 2, 2024 Read MoreFractyl Health (GUTS) priced its IPO at the $15.00 mid-point of its $14.00-to-$16.00 range – and kept the deal’s size at the 7.33 million shares in the prospectus – to raise $109.95 million on Thursday night, Feb. 1, 2024. The metabolic therapeutics company is targeting obesity and Type 2 diabetes. The stock dropped below its […]
February 1, 2024 Read MoreAlto Neuroscience (ANRO) priced its upsized IPO at $16.00 – the high end of its $14.00-to-$16.00 range. The company increased the deal’s size to 8.04 million shares – up from 6.7 million shares in the prospectus – and raised $128.64 million on Thursday night, Feb. 1, 2024. The Phase 2 clinical biotech is developing drugs […]
Read More